Endometrial Neoplasm — Trials

Endometrial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,340 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 201–250 of 453 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06502743	First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab, Followed by Maintenance Pembrolizumab With or Without Nesuparib, in Patients With Newly Diagnosed Advanced or Recurrent MMR-proficient (pMMR) Endometrial Cancer(PENELOPE)	recruiting	Phase 2	92	Yonsei UniversityOTHER	1	Apr 3, 2025	clinicaltrials
NCT06385548	Efficacy and Safety Study of Lurbinectedin and Dostarlimab in Cancer Patients: Protocol VHIO21001 - LiDer(LiDer)	withdrawn	Phase 1 / Phase 2	0	Vall d'Hebron Institute of Oncology